Work Here?
About Aetion
Industries
AI & Machine Learning
Healthcare
Company Size
201-500
Company Stage
Series C
Total Funding
$198M
Headquarters
New York City, New York
Founded
2012
Overview
Aetion develops software solutions that utilize real-world evidence (RWE) to assist life sciences companies, regulators, and purchasers in making informed decisions. Their software analyzes real-world data to provide insights into the effectiveness and safety of medical innovations, from initial hypotheses to long-term monitoring. Aetion's clients include major pharmaceutical companies and healthcare regulators, who benefit from the ability to generate and analyze diverse data sets for clinical insights that were previously hard to obtain. The company differentiates itself by offering a platform that not only manages longitudinal data but also generates synthetic health data using artificial intelligence. Aetion's goal is to maximize the return on investment for its clients by providing rapid insights that facilitate critical decision-making, ultimately expediting patient care.
Simplify's Take
What believers are saying
- Aetion's partnership with NEC expands its market reach using Japanese health records.
- The Barcelona technology hub leverages European talent for accelerated product development.
- FDA collaboration boosts Aetion's credibility in regulatory decisions using real-world data.
What critics are saying
- Increasing competition in RWE technology could threaten Aetion's market share.
- Rapid AI advancements may outpace Aetion's current offerings, requiring continuous innovation.
- Geopolitical risks and regulatory challenges may arise from international market expansions.
What makes Aetion unique
- Aetion's platform uses real-world data to provide evidence for medical treatment effectiveness.
- The company collaborates with biopharmaceutical and medical device companies for real-time insights.
- Aetion's patented rapid-cycle analytics technology sets it apart in the healthcare sector.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$198M
Above
Industry Average
Funded Over
3 Rounds
New Enterprise AssociatesIndustry standards
Benefits
Medical, dental, & vision insurance
Free membership to OneMedical
FSA
4% 401(k) match
Commuter benefits for parking & transit
Unlimited PTO
Paid parental leave
Wellness stipend
Company activities
Growth & Insights and Company News
6 month growth
↑ 1%1 year growth
↑ 3%2 year growth
↑ 1%NEC's CVC fund, NEC Orchestrating Future Fund, has invested in Aetion, Inc., a U.S. company providing a medical data analysis platform. This investment aims to enhance collaboration in utilizing real-world data (RWD) and real-world evidence (RWE) for drug development. Aetion's platform, Aetion Evidence Platform, is used globally by pharmaceutical companies and healthcare organizations to improve decision-making. NEC and Aetion will explore synergies to streamline drug development processes.
NEC Orchestrating Future Fund (NOFF) has invested in Aetion, a leader in real-world evidence technology. NEC and Aetion will collaborate to use Japanese electronic health records for drug development via Aetion's Substantiate® application. This partnership aims to enhance drug development efficiency and regulatory pathways. Aetion's platform uses AI and privacy-preserving techniques to transform real-world data into evidence, supporting personalized medicine and next-gen healthcare.
Aetion, the global leader in real-world evidence (RWE) technology and analytics, today announced the appointment of Kevin Riley as president.
BARCELONA, Spanien, 25. Juni 2024 /PRNewswire/ -- Aetion®, der weltweit führende Anbieter von Real-World-Evidence (RWE)-Technologien und -Analysen, gab heute die Gründung eines RWE-Technologiezentrums in Barcelona, Spanien, bekannt, in dem die fähigste Gruppe engagierter RWE-Technologen der Branche zusammenkommt. Aetion gab außerdem die Ernennung von Ken Watson zum Chief Technology Officer (CTO) bekannt. Ken kann auf jahrzehntelange Erfahrung bei Unternehmen wie Microsoft, der Toronto Stock Exchange und WeWork sowie bei mehreren von ihm mitbegründeten Start-ups zurückgreifen und ist für die Leitung der gesamten Entwicklungs- und Produktstrategie von Aetion verantwortlich.Aetion gründete 2021 eine Niederlassung in Barcelona und hat sein Team dort seither kontinuierlich ausgebaut. Im Rahmen des Starts seines Technologiezentrums wird Aetion die Größe seines Ingenieurteams in Spanien mehr als verdoppeln und technische Spitzenkräfte vor Ort und aus ganz Europa anziehen. Das Team in Barcelona wird an der gesamten Produktpalette von Aetion arbeiten, um bestehende Angebote zu verbessern und weiterhin Innovationen an der Spitze der RWE-Technologie zu entwickeln
BARCELONE, Espagne, 25 juin 2024 /PRNewswire/ -- Aetion®, le leader mondial de la technologie et de l'analyse des données probantes du monde réel (DPMR), a annoncé aujourd'hui la création d'un pôle technologique DPMR à Barcelone, en Espagne, afin de réunir le groupe le plus compétent de technologues dédiés au DPMR dans l'industrie. Aetion a également annoncé la nomination de Ken Watson au poste de directeur des techniques informatiques (DTI). Ken s'appuie sur ses dizaines d'années d'expérience dans des entreprises telles que Microsoft, la Bourse de Toronto et WeWork - ainsi que dans plusieurs start-ups qu'il a cofondées - et est responsable de la stratégie globale d'Aetion en matière d'ingénierie et de produits.Aetion s'est implantée à Barcelone en 2021 et y a régulièrement développé son équipe depuis. Dans le cadre du lancement de son centre technologique, Aetion va plus que doubler la taille de son équipe d'ingénieurs en Espagne, en attirant les meilleurs talents techniques locaux et de toute l'Europe. L'équipe de Barcelone travaillera sur l'ensemble des produits d'Aetion, améliorant les offres existantes et continuant à innover à la pointe de la technologie DPMR. Le lancement récent d'Aetion® Discover - le premier produit Aetion construit à Barcelone - a marqué un tournant dans l'établissement de la ville en tant que nouveau centre technologique d'Aetion
Aetion is Hiring for 0 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Aetion
Industries
AI & Machine Learning
Healthcare
Company Size
201-500
Company Stage
Series C
Total Funding
$198M
Headquarters
New York City, New York
Founded
2012
Aetion is Hiring for 0 Jobs on Simplify!
Find jobs on Simplify and start your career today